ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,475Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 384

$745K Total Retail Price of All Prescriptions

Rank: 21 out of 384

592 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 592 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

2% of this provider’s 592 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

3% of this provider’s 15,989 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$32 was the average price of a prescription from this provider, compared to $45 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 1,495 1,038 1 1
GABAPENTIN 1,074 651 2 4
LOSARTAN-HYDROCHLOROTHIAZIDE 976 631 3 10
RANITIDINE HCL 882 636 4 7
OMEPRAZOLE 768 510 5 8
ENALAPRIL MALEATE 698 472 6 6
TRAMADOL HCL-ACETAMINOPHEN 635 447 7 13
METFORMIN HCL 632 469 8 2
SYNTHROID 580 421 9 9
HYDROCHLOROTHIAZIDE 486 359 10 16
AMLODIPINE BESYLATE 484 390 11 3
LEVOTHYROXINE SODIUM 429 368 12 11
LOVASTATIN 424 264 13 80
GLIPIZIDE 395 297 14 27
ATENOLOL 376 263 15 12
DICLOFENAC SODIUM 369 252 16 81
GLYBURIDE-METFORMIN HCL 369 244 R 16 64
PRAVASTATIN SODIUM 346 218 18 24
LOSARTAN POTASSIUM 323 212 19 5
GLIMEPIRIDE 321 192 20 18
ALENDRONATE SODIUM 299 243 21 20
CILOSTAZOL 290 223 22 70
FUROSEMIDE 282 200 23 17
ENALAPRIL-HYDROCHLOROTHIAZIDE 251 181 10 24 134
ATENOLOL-CHLORTHALIDONE 251 161 24 173
METOPROLOL TARTRATE 240 203 26 15
FLUTICASONE PROPIONATE 218 145 27 61
CLOTRIMAZOLE-BETAMETHASONE 216 139 28 58
SURE COMFORT 212 169 29 96
SULINDAC 210 145 30 79
DICLOFENAC POTASSIUM 207 156 31 38
CLOPIDOGREL 204 169 32 30
PLAVIX 200 157 33 32
ZOLPIDEM TARTRATE 186 127 34 19
DOXAZOSIN MESYLATE 181 164 35 29
GEMFIBROZIL 176 86 36 74
CLONIDINE HCL 171 127 37 84
HUMULIN 70-30 170 84 38 47
DEXAMETHASONE 164 106 39 117
ZETIA 160 93 40 69
ASPIRIN EC 148 104 41 31
CIPROFLOXACIN HCL 142 106 42 50
ISOSORBIDE MONONITRATE ER 137 125 43 28
VERAPAMIL ER 137 79 43 41
TRAMADOL HCL 130 92 45 40
FAMOTIDINE 128 89 46 35
EVISTA 120 86 47 52
LANTUS 117 57 48 42
CARVEDILOL 115 96 49 23
CAPTOPRIL 114 103 50 72
ISOSORBIDE DINITRATE 111 92 51 118
AZITHROMYCIN 110 52 52 59
MECLIZINE HCL 104 96 53 73
OXYCODONE-ACETAMINOPHEN 104 18 S2 53 93
HUMULIN N 103 69 55 57
TAMSULOSIN HCL 100 72 56 25
PENTOXIFYLLINE 96 70 57 113
PANTOPRAZOLE SODIUM 96 70 57 39
NALBUPHINE HCL 92 0 10 59 295
SINGULAIR 81 34 60 63
DIPYRIDAMOLE 79 53 R 61 97
NAPROXEN SODIUM 78 45 62 164
CYMBALTA 75 42 63 71
DIOVAN HCT 75 67 63 66
DIOVAN 74 62 65 54
AMLODIPINE BESYLATE-BENAZEPRIL 73 46 66 43
GLYBURIDE 70 58 R 67 82
CRESTOR 69 60 68 45
SUCRALFATE 69 53 68 246
DONEPEZIL HCL 68 56 70 33
NABUMETONE 67 32 71 34
METOPROLOL SUCCINATE 67 50 71 21
HUMALOG MIX 75-25 66 34 73 104
HYDROXYZINE HCL 61 37 R 74 211
ATORVASTATIN CALCIUM 61 29 74 22
FEXOFENADINE HCL 60 29 76 227
DILTIAZEM 24HR CD 56 31 77 137
LISINOPRIL 52 28 78 14
WARFARIN SODIUM 52 29 78 48
FOSINOPRIL SODIUM 51 51 80 132
IBANDRONATE SODIUM 51 29 80 219
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 1, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.